Tag: Ehave - Psychedelic Alpha

Read more about the article Ehave Provides Progress Update on its HPPD Study with University of Melbourne

Ehave Provides Progress Update on its HPPD Study with University of Melbourne

Post published:February 2, 2023
Post category:Press Release

Read more about the article FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder

FDA Grants Ehave Consent to Proceed With Its Clinical Study on Intravenous Ketamine Infusion for Major Depressive Disorder

Post published:December 15, 2022
Post category:Press Release

Read more about the article Ehave Shareholder from CEO Ben Kaplan and Corporate Update

Ehave Shareholder from CEO Ben Kaplan and Corporate Update

Post published:December 7, 2022
Post category:Press Release

Read more about the article Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to Miami Beach on June 10, 2022

Ehave, Inc. Announces its KetaDASH Mobile Unit will be Delivered to Miami Beach on June 10, 2022

Post published:June 3, 2022
Post category:Press Release

Read more about the article Ehave Forms Partnership with Cognitive Apps to Introduce Revolutionary AI Voice Assistant That Will Revolutionize Mental Health in Psychedelic Sector

Ehave Forms Partnership with Cognitive Apps to Introduce Revolutionary AI Voice Assistant That Will Revolutionize Mental Health in Psychedelic Sector

Post published:January 11, 2021
Post category:Press Release

Read more about the article Ehave, Inc. Partners with Cognitive Apps to Add Artificial Intelligence-Powered Mental Health Analytical Platform for Psychedelic Use in G20 Countries

Ehave, Inc. Partners with Cognitive Apps to Add Artificial Intelligence-Powered Mental Health Analytical Platform for Psychedelic Use in G20 Countries

Post published:January 7, 2021
Post category:Press Release

Read more about the article Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange

Ehave, Inc. Files to List on the Canadian Stock Exchange and Applies to Upgrade to OTCQB Exchange

Post published:January 4, 2021
Post category:Press Release

Read more about the article Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value

Ehave, Inc. Announces Repositioning of Mycotopia Therapies to Maximize Shareholder Value

Post published:December 28, 2020
Post category:Press Release

Read more about the article Ehave KetaDASH Subsidiary Announces Intent to Battle Major Depression through Home Delivery of Ketamine

Ehave KetaDASH Subsidiary Announces Intent to Battle Major Depression through Home Delivery of Ketamine

Post published:December 23, 2020
Post category:Press Release

Read more about the article Ehave, Inc. Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021

Ehave, Inc. Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021

Post published:December 17, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.